Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OZLASE study of Ozurdex plus macular laser versus macular laser alone in diabetic macular oedema
2011-003339-74Phase 3Completed
- Sponsor
- Moorfields Eye Hospital
- Start
- Aug 2011
- Modality
- Small Molecules, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ozurdex in diabetic macular edema (DME) (2 arms), sponsored by Moorfields Eye Hospital. Primary endpoint: Mean BCVA letter score difference at week 56. Started Aug 2011; status: completed.
02
Drugs
ozurdex
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2011-003339-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003339-74.